Literature DB >> 8852415

Pre-exposure rabies prophylaxis for the international traveller: a decision analysis.

P LeGuerrier1, P A Pilon, D Deshaies, R Allard.   

Abstract

To determine for which travellers pre-exposure rabies prophylaxis is indicated, a decision tree-based model has been developed which enables the comparison of one million travellers going to rabies-endemic areas who receive a pre-exposure rabies prophylaxis to one million travellers also going to rabies-endemic areas who are not vaccinated. Using data obtained from a review of the literature, probabilities were assigned to each significant outcome. When numbers were not available, estimates were used and tested with a sensitivity analysis. Routine pre-exposure prophylaxis would prevent 0.054 cases per million adult travellers per month at a cost of 5 billion (thousand million) Canadian dollars. In the worst-case scenario, which concerns children, the cost per case prevented per year of stay would be $275,000 dollars. Our decision analysis leads us to believe that routine pre-exposure prophylaxis given to travellers heading for rabies-endemic regions of the world is not indicated. We conclude that pre-exposure rabies prophylaxis is a medical decision that must be individualized for every traveller and should be particularly considered for children at high risk of being exposed to rabies, who are leaving for a long stay (more than one year) and who will not have rapid access to medical services and rabies immunobiologics.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8852415     DOI: 10.1016/0264-410x(95)00110-m

Source DB:  PubMed          Journal:  Vaccine        ISSN: 0264-410X            Impact factor:   3.641


  5 in total

1.  Rabies exposure risk among foreign backpackers in Southeast Asia.

Authors:  Watcharapong Piyaphanee; Prapimporn Shantavasinkul; Weerapong Phumratanaprapin; Piyada Udomchaisakul; Pongdej Wichianprasat; Maneerat Benjavongkulchai; Thitiya Ponam; Terapong Tantawichian
Journal:  Am J Trop Med Hyg       Date:  2010-06       Impact factor: 2.345

Review 2.  A review of the economics of the prevention and control of rabies. Part 1: Global impact and rabies in humans.

Authors:  M I Meltzer; C E Rupprecht
Journal:  Pharmacoeconomics       Date:  1998-10       Impact factor: 4.981

3.  Intravitam diagnosis of human rabies by PCR using saliva and cerebrospinal fluid.

Authors:  P Crepin; L Audry; Y Rotivel; A Gacoin; C Caroff; H Bourhy
Journal:  J Clin Microbiol       Date:  1998-04       Impact factor: 5.948

4.  Risk of potentially rabid animal exposure among foreign travelers in Southeast Asia.

Authors:  Watcharapong Piyaphanee; Chatporn Kittitrakul; Saranath Lawpoolsri; Philippe Gautret; Wataru Kashino; Waraluk Tangkanakul; Prangthip Charoenpong; Thitiya Ponam; Suda Sibunruang; Weerapong Phumratanaprapin; Terapong Tantawichien
Journal:  PLoS Negl Trop Dis       Date:  2012-09-27

5.  Rabies vaccination strategies in the Netherlands in 2018: a cost evaluation.

Authors:  Anita Wm Suijkerbuijk; Marie-Josee J Mangen; Manon R Haverkate; Floriana S Luppino; Sabine E Bantjes; Leo G Visser; Corien M Swaan; Wilhelmina Lm Ruijs; Eelco Ab Over
Journal:  Euro Surveill       Date:  2020-09
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.